147 related articles for article (PubMed ID: 35251152)
1. Intelligent Diagnosis and Analysis of Brain Lymphoma Based on DSC Imaging Features.
Mao Y; Jiang M; Zhao F; Long L
Comput Intell Neurosci; 2022; 2022():4981620. PubMed ID: 35251152
[TBL] [Abstract][Full Text] [Related]
2. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
3. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous perfusion and permeability assessments using multiband multi-echo EPI (M2-EPI) in brain tumors.
Wu J; Saindane AM; Zhong X; Qiu D
Magn Reson Med; 2019 Mar; 81(3):1755-1768. PubMed ID: 30298595
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
6. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasmosis versus lymphoma: Cerebral lesion characterization using DSC-MRI revisited.
Dibble EH; Boxerman JL; Baird GL; Donahue JE; Rogg JM
Clin Neurol Neurosurg; 2017 Jan; 152():84-89. PubMed ID: 27940418
[TBL] [Abstract][Full Text] [Related]
9. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
10. Comparison between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labeling techniques in distinguishing malignant from benign brain tumors.
Ata ES; Turgut M; Eraslan C; Dayanır YÖ
Eur J Radiol; 2016 Sep; 85(9):1545-53. PubMed ID: 27501887
[TBL] [Abstract][Full Text] [Related]
11. Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease.
Cavallin L; Axelsson R; Wahlund LO; Oksengard AR; Svensson L; Juhlin P; Wiberg MK; Frank A
Acta Radiol; 2008 Dec; 49(10):1154-61. PubMed ID: 18855165
[TBL] [Abstract][Full Text] [Related]
12. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
[TBL] [Abstract][Full Text] [Related]
13. Effects of Susceptibility Artifacts on Perfusion MRI in Patients with Primary Brain Tumor: A Comparison of Arterial Spin-Labeling versus DSC.
Maral H; Ertekin E; Tunçyürek Ö; Özsunar Y
AJNR Am J Neuroradiol; 2020 Feb; 41(2):255-261. PubMed ID: 31974077
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
[TBL] [Abstract][Full Text] [Related]
16. Joint approach of diffusion- and perfusion-weighted MRI in intra-axial mass like lesions in clinical practice simulation.
Yoon RG; Kim HS; Hong GS; Park JE; Jung SC; Kim SJ; Kim JH
PLoS One; 2018; 13(9):e0202891. PubMed ID: 30192785
[TBL] [Abstract][Full Text] [Related]
17. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
18. CT, conventional, and functional MRI features of skull lymphoma: a series of eight cases in a single institution.
Xing Z; Huang H; Xiao Z; Yang X; Lin Y; Cao D
Skeletal Radiol; 2019 Jun; 48(6):897-905. PubMed ID: 30310943
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]